Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supply, especially during periods of disruption.

In the pharmaceutical industry, equipment failures, changing operating conditions and other unexpected occurrences can cause batch failures, resulting in costly production losses and disruptions to supply. So how can companies maintain the security of supply while protecting profits?

Unexpected disturbances and shutdowns can severely impact any manufacturing facility. The AspenTech APM 4.0 portfolio uses agents that can be replicated quickly and easily across all plant assets to assure production and avoid unnecessary maintenance. Learn how APM 4.0 delivers an all-inclusive approach to efficiency, productivity and safety to support operational excellence in plant operations and the bottom line for manufacturers.

We are excited to announce OPTIMIZE 24, our worldwide user conference, taking place April 29–May 3 in Houston, Texas.

AspenTech provides AI-enabled digital solutions that help customers optimize outcomes across the pharma value chain network using a holistic approach to digital transformation in an ever-changing world. Learn how our approach ensures the security of supply and pushes the boundaries and limits of what is possible for optimization, multiplying performance gains from digital transformation in this video.

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Learn how Pharmaceutical and Biotech Companies can use Data and AI with confidence in this brief video about our research report.

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.

If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance.

Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to ensure successful batches. The Camo solution for batch monitoring uses batch trajectory trending with smarter deviation detection to anticipate the process flow, so operators have time to act and can stay on top of production to ensure product quality and reduce waste.